Sony and Singapore’s GIC to invest $2 billion in music catalogs

Sony Music Group and Singapore’s GIC sovereign wealth fund are forming a joint venture to acquire music copyrights, planning to invest between $2 billion and $3 billion. The move will allow the Japanese entertainment giant to expand its song portfolio.

Announced on Wednesday, January 29, 2026, the joint venture will see Sony Music Group, the music division of Sony Group, manage the acquired catalogs. This includes distributing songs to streaming services and licensing older tracks for use in films and commercials. GIC will provide capital and investment expertise.

As one of the world’s largest record companies, Sony Music aims to build up its portfolio of copyrights through this project. Girish Karira, head of GIC’s integrated strategies group, said in a statement: “As a long-term investor, GIC seeks to be a creative and flexible capital partner to strategic industry leaders like Sony.”

The partnership highlights the growing importance of music copyrights as a stable revenue source amid the digitalization of the industry and the rise of streaming. It positions Sony to strengthen its presence in the global entertainment market.

Liittyvät artikkelit

Sony Pictures Entertainment and Netflix have signed a new multi-year pay-1 licensing agreement, granting the streamer global rights to Sony's feature films after their theatrical and home entertainment windows. The deal, which builds on their 2021 U.S.-focused partnership, will roll out gradually starting later in 2026 and achieve full worldwide availability by early 2029. Financial terms remain undisclosed, but it surpasses the previous $2.5 billion arrangement in value.

Raportoinut AI

Netflix has struck a landmark global agreement with Sony Pictures Entertainment, securing exclusive Pay-1 streaming rights for Sony's theatrical films worldwide. The deal, described as first-of-its-kind, includes major upcoming releases like the live-action Legend of Zelda movie. It expands an existing partnership to cover every Netflix market, with rollout starting in 2026.

Global institutional investors have built sizeable positions in China's largest biotech firms, including Innovent, 3SBio, WuXi Biologics, Jiangsu Hengrui, Akeso and BeOne. These companies, all constituents of the Hang Seng Biotech Index, are gaining importance on the global stage. Foreign investors, from sovereign wealth funds to industry players, are securing strategic stakes in their future success.

Raportoinut AI

The Japanese government plans to require screening by an intelligence body for foreign companies and investors before they invest in Japanese firms if national security risks are high. In 2026, it will establish a new organization equivalent to the U.S. Committee on Foreign Investment in the United States (CFIUS) to participate in these reviews. The goal is to prevent the leakage of technologies and information held by Japanese companies overseas.

 

 

 

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää